Evaluation of monocyte chemotactic protein (MCP-1) in saliva as an early sign of metabolic disorders in patients with chronic kidney disease / Eman Magdy Ahmed Mohamed ; Supervised Soheir Mohamed Gaafar , Laila Mohamed Rashed , Weaam Rashwan
Material type:
- للوحيدات فى اللعاب كمؤشر أولى لمشكلات الأيض لدى مرضى القصور الكلوى المزمن (MCP-1)تقييم البروتين الكيميائى [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.09.08.M.Sc.2014.Em.E (Browse shelf(Opens below)) | Not for loan | 01010110065011000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.09.08.M.Sc.2014.Em.E (Browse shelf(Opens below)) | 65011.CD | Not for loan | 01020110065011000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Oral and Dental Medicine - Department of Periodontology
Chronic kidney disease incidence have been rising since the publication of the practical guidelines by the Kidney Disease Outcomes Quality Initiation (KDOQI) of the National Kidney Foundation (NKF) in 2002 to reach 200 case per million in many countries around the world with survival rate 3 to 5 years. There are many mechanisms by which chronic kidney disease can affect the oral cavity; uremia, hyperparathyroid hormone, anemia, oxidative stress and and the dramatic rise in inflammatory mediators such as IL-1, IL-6,TNF-Ü, CRP and MCP-1. The oral mucosa, salivary glands, teeth and even periodontal tissues all are affected by the disease.Complications of chronic kidney disease could be prevented if the condition was early detected and controlled; metabolic complications and cardiovascular complication are the most serious complications of chronic kidney disease; both can be early detected and controlled. One successful approach to control the complications is to monitor the inflammatory mediators such as MCP-1a key chemokine; its increasing level translates the decline in renal function and predates the onset of its serious complications
Issued also as CD
There are no comments on this title.